Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–50 of 749 results
Advanced filters: Author: David Cyranoski Clear advanced filters
  • The World Conference on Disaster Reduction, hosted by the United Nations in Kobe, Japan, from 18-22 January, comes at a good time: in the wake of December's tsunami, researchers and policy makers are both keen to do as much as possible to reduce the death count from future disasters. David Cyranoski reports back from the conference.

    • David Cyranoski
    Blogs
    Nature
  • How did a mud volcano come to destroy an Indonesian town? David Cyranoski reports from Sidoarjo.

    • David Cyranoski
    News
    Nature
    Volume: 445, P: 812-815
  • A quick guide to the people behind the Woo Suk Hwang story.

    • David Cyranoski
    News
    Nature
  • Can a vast monoculture plantation be at the forefront of biodiversity protection? David Cyranoski meets conservation biologists who hope to save species by making peace with the enemy.

    • David Cyranoski
    News
    Nature
    Volume: 446, P: 608-610
  • From artificial intelligence to infectious diseases, top researchers in Hong Kong, Malaysia, Singapore, South Korea and Taiwan are making big impacts on the global stage.

    • David Cyranoski
    • Yao-Hua Law
    • Mark Zastrow
    News
    Nature
    Volume: 558, P: 502-510
  • The Japanese make few charitable donations. David Cyranoski meets a patient advocate and scientist working to change a cultural reticence about giving.

    • David Cyranoski
    News
    Nature
    Volume: 450, P: 24-25
  • Sequencing the DNA of the world's leading food crop was the easy part. Now comes the tricky task of turning our new knowledge of the rice genome into agricultural and economic gains. David Cyranoski reports.

    • David Cyranoski
    News
    Nature
    Volume: 422, P: 796-798
  • A team in Seoul has stolen a march with its work towards human therapeutic cloning. The researchers have been fêted, but an ethical controversy may threaten their work. David Cyranoski investigates.

    • David Cyranoski
    News
    Nature
    Volume: 429, P: 12-14
  • Japan wants to reform its university system, in part to match the competitive and entrepreneurial spirit of US academia. That won't be easy, says David Cyranoski.

    • David Cyranoski
    News
    Nature
    Volume: 419, P: 875-876
  • Thousands of patients are queueing to be treated by Hongyun Huang at his Beijing clinic. But no Western journal editor seems willing to publish his research. David Cyranoski talks to the neurosurgeon whose global reputation among the ailing hasn't swayed his peers.

    • David Cyranoski
    News
    Nature
    Volume: 437, P: 810-811
  • Companies and scientists in the West are keen to test their drugs in China, which is an important future market. But those running clinical trials need to be on their guard, says David Cyranoski.

    • David Cyranoski
    News
    Nature
    Volume: 435, P: 138
  • The bold ambitions of one institute could make China the world leader in genome sequencing. David Cyranoski asks if its science will survive the industrial ramp-up.

    • David Cyranoski
    News
    Nature
    Volume: 464, P: 22-24
  • Last November, a shock wave crippled Japan's Super-Kamiokande neutrino detector. David Cyranoski and Geoff Brumfiel find out how physicists plan to resurrect the device.

    • David Cyranoski
    • Geoff Brumfiel
    News
    Nature
    Volume: 416, P: 118-119
  • Why did Hwang fake his data, how did he get away with it, and how was the fraud found out?

    • David Cyranoski
    News
    Nature
  • Malaysia's research system is closed and isolated. What are scientists with a yen for rigorous research to do? David Cyranoski finds out.

    • David Cyranoski
    Comments & Opinion
    Nature
    Volume: 436, P: 884-885
  • Ten years ago, Woo Suk Hwang rose to the top of his field before fraud and dodgy bioethical practices derailed his career. Can a scientific pariah redeem himself?

    • David Cyranoski
    News
    Nature
    Volume: 505, P: 468-471
  • Can the Chinese government meet its ambitious targets on space, the environment, research, energy and health? David Cyranoski takes a look at China today and what it hopes to be tomorrow.

    • David Cyranoski
    News
    Nature
    Volume: 454, P: 384-387
  • Singapore, the fastest growing economy in Asia last year, has enjoyed a decade of free-flowing research funding. Money is still pouring in, but the question remains whether money can buy international-class science. Sir George Radda, who was appointed chairman of the city-state’s Biomedical Research Council (BMRC) in 2009, talks with David Cyranoski about what’s ahead for Singapore.

    • David Cyranoski
    News
    Nature Medicine
    Volume: 17, P: 525
  • China produces fine scientists, but too many go abroad for training and do not return. David Cyranoski visits a programme that aims to give scientific high-fliers a reason to stay put.

    • David Cyranoski
    News
    Nature
    Volume: 417, P: 683
  • As a much-hailed breakthrough in stem-cell science unravelled this year, many have been asking: ‘Where were the safeguards?’

    • David Cyranoski
    News
    Nature
    Volume: 511, P: 140-143
  • Hiroaki Serizawa's promising US academic career was ruined when a favour to a friend led to him being charged with economic espionage on behalf of Japan. He tells his story to David Cyranoski.

    • David Cyranoski
    News
    Nature
    Volume: 430, P: 960-961
  • Earthquake geologist Kerry Sieh of the California Institute of Technology in Pasadena is moving to Singapore in July to head the new S$300 million (US$220 million) Earth Observatory of Singapore. He talks to David Cyranoski.

    • David Cyranoski
    News
    Nature
    Volume: 452, P: 791
  • With keen immunological insight and a knockout mouse 'factory', Shizuo Akira leads by quiet example. David Cyranoski visits the world's most-cited scientist as he prepares to run one of Japan's premier research centres.

    • David Cyranoski
    News
    Nature
    Volume: 450, P: 475-477
  • A Chinese laboratory is the only source of a valuable crystal. David Cyranoski investigates why it won't share its supplies.

    • David Cyranoski
    News
    Nature
    Volume: 457, P: 953-955
  • When landfills overflow, governments need new ways to deal with garbage. David Cyranoski visits a plant in Japan where plasma technology is turning waste into energy.

    • David Cyranoski
    News
    Nature
    Volume: 444, P: 262-263
  • Singapore's impressive advances in biomedicine are driven by the energetic personality of Philip Yeo. David Cyranoski meets a man who just can’t stand still.

    • David Cyranoski
    News
    Nature
    Volume: 436, P: 767-768
  • Nature catches up with some past fraud investigations — and finds that, whether researchers are found to be guilty or innocent, the wounds are slow to heal.

    • Lucy Odling-Smee
    • Jim Giles
    • Emma Marris
    News
    Nature
    Volume: 445, P: 244-245
  • Genome Institute of Singapore head Edison Liu talks about how to make pan-Asian genomics research projects work.

    • David Cyranoski
    News
    Nature
    Volume: 456, P: 12
  • South Korean researcher reveals the fallout he faced from his tip-offs about former cloning fraudster Woo Suk Hwang.

    • David Cyranoski
    News
    Nature
    Volume: 505, P: 593-594
  • Woo Suk Hwang's former collaborator emerges from the shadow of scandal.

    • David Cyranoski
    News
    Nature
  • Mount Fuji is a cultural icon and Japan's most important geological feature. Yet until it began rumbling a few years ago, scientists had almost completely ignored it, says David Cyranoski. Is it preparing to erupt again?

    • David Cyranoski
    News
    Nature
    Volume: 428, P: 12-13
  • If North Korea has nuclear weapons, its neighbours may want to develop their own. Geoff Brumfiel and David Cyranoski ask whether Japanese and South Korean scientists would answer a call to nuclear arms.

    • David Cyranoski
    • Geoff Brumfiel
    News
    Nature
    Volume: 423, P: 110-111
  • Once a poor village, Shenzhen is now one of the wealthiest cities in China. David Cyranoski learns its plans for the future.

    • David Cyranoski
    Comments & Opinion
    Nature
    Volume: 449, P: 502-504
  • Universities can now profit from their creativity, but not all academics are pleased.

    • David Cyranoski
    Research
    Nature
    Volume: 429, P: 216-219